In anticancer immunity, the complex interaction between immune cells such as NK, CD4+ T, and CD8+ T cells can significantly affect the survival rate, which has been reported in tumor‐infiltrating lymphocytes in pancreatic cancer.7 This evidence concerns the gene CD8A and neoplasm.